Related Experiment Video

Updated: Aug 23, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

[Cardiogenic shock in acute coronary syndrome--therapeutic approach]

Vjeran Nikolić Heitzler1, Zdravko Babić, Sime Manola

  • 1Koronarna jedinica, Zavod za kardiovaskularne bolesti Interne klinike, Klinicka bolnica Sestre milosrdnice, Vinogradska 29 10000 Zagreb, Hrvatska.

Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti
|June 24, 2004
PubMed

Insights

Primary percutaneous coronary intervention (PCI) significantly reduces mortality in acute ST-elevation myocardial infarction (STEMI) patients experiencing cardiogenic shock. This vital treatment lowers the death rate from 80% to 35% in STEMI cases.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Context:

  • Cardiogenic shock is a severe complication of acute coronary syndromes.
  • Mortality rates for cardiogenic shock have historically been high, especially with conservative treatment.

Purpose:

  • To assess the incidence and mortality rates of cardiogenic shock in patients with ST-elevation myocardial infarction (STEMI).
  • To evaluate the effectiveness of primary percutaneous coronary intervention (PCI) in treating STEMI-induced cardiogenic shock.

Summary:

  • The study included 701 STEMI patients, with 312 treated with primary PCI.
  • The incidence of cardiogenic shock among STEMI patients was found to be 8.3%.
  • Primary PCI reduced the mortality rate for cardiogenic shock in STEMI patients from 80% to 35%.

Impact:

  • Primary PCI has emerged as the definitive therapy for cardiogenic shock complicating STEMI.
  • This intervention significantly improves survival rates for a critical patient group.
  • The findings support the widespread adoption of primary PCI in managing STEMI with cardiogenic shock.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...